US Bancorp’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $77.8K | Sell |
2,394
-2,950
| -55% | -$95.9K | ﹤0.01% | 2562 |
|
2025
Q1 | $202K | Buy |
5,344
+357
| +7% | +$13.5K | ﹤0.01% | 1989 |
|
2024
Q4 | $408K | Sell |
4,987
-2,055
| -29% | -$168K | ﹤0.01% | 1607 |
|
2024
Q3 | $805K | Sell |
7,042
-1,958
| -22% | -$224K | ﹤0.01% | 1243 |
|
2024
Q2 | $680K | Buy |
9,000
+1,505
| +20% | +$114K | ﹤0.01% | 1303 |
|
2024
Q1 | $512K | Sell |
7,495
-9,035
| -55% | -$617K | ﹤0.01% | 1491 |
|
2023
Q4 | $1.04M | Sell |
16,530
-3,652
| -18% | -$229K | ﹤0.01% | 1095 |
|
2023
Q3 | $1.03M | Buy |
20,182
+19,484
| +2,791% | +$993K | ﹤0.01% | 1039 |
|
2023
Q2 | $34.9K | Sell |
698
-156
| -18% | -$7.79K | ﹤0.01% | 2674 |
|
2023
Q1 | $32K | Sell |
854
-71
| -8% | -$2.66K | ﹤0.01% | 2738 |
|
2022
Q4 | $44.4K | Buy |
925
+815
| +741% | +$39.1K | ﹤0.01% | 2596 |
|
2022
Q3 | $3K | Buy |
+110
| New | +$3K | ﹤0.01% | 3726 |
|